GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $5,514,000 | -90.5% | 100,000 | -86.3% | 0.14% | -95.1% |
Q4 2019 | $58,028,000 | -39.1% | 730,000 | -59.4% | 2.95% | -37.8% |
Q1 2019 | $95,274,000 | +3.2% | 1,800,000 | -20.0% | 4.75% | +8.3% |
Q4 2018 | $92,363,000 | +17.1% | 2,250,000 | +8.4% | 4.38% | +29.9% |
Q3 2018 | $78,850,000 | -20.7% | 2,075,000 | -5.7% | 3.37% | -11.8% |
Q2 2018 | $99,440,000 | +71.6% | 2,200,000 | +83.3% | 3.83% | +34.4% |
Q1 2018 | $57,960,000 | +84.1% | 1,200,000 | +50.0% | 2.85% | +84.7% |
Q4 2017 | $31,480,000 | – | 800,000 | – | 1.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
Grace Capital | 124,749 | $6,878,000 | 5.33% |
Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |